查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362873

女性健康診斷市場規模、佔有率和趨勢分析報告：按最終用途、用途、地區和細分市場預測，2023-2030 年

Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

女性健康診斷市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球女性健康診斷市場預計將達到 314 億美元。

預計2023年至2030年該市場將以7.3%的年複合成長率擴張。擴大採用現場診斷、各種慢性病和文明病的罹患率是刺激市場成長的主要要素。除此之外，預計各種宣傳計畫的推出也將在預測期內有利於市場。例如，2014年，歐盟委員會聯合推出了《歐洲提高癌症綜合控制品質指南》。

由於各組織的資金增加，女性健康診斷顯示出高速成長。例如，2015年5月，Abcodia與Cambridge Innovative Capital、Scottish Equity Partners和Albion Ventures合作，在英國推出用於早期發現卵巢癌的卵巢癌風險演算法（ROCA）測試，獲得了800萬美元的資金加州大學洛杉磯分校。

依最終用途，市場分為醫院/診斷中心和家庭使用。由於醫院就診次數多且檢測更可靠，醫院和診斷中心佔據了很大的市場。

亞太市場在未來年度可能會顯著成長。該市場的成長是由醫療保健投資的增加、國際設備製造商專注於加強其在該地區的銷售網路以及該地區流行病學從感染疾病到慢性病的不斷轉變所推動的，這是由於持續的轉變。

女性健康診斷市場報告亮點

  • 政府和私人實體投資的增加以及可支配所得的增加正在提振市場。
  • 2017年癌症的市場佔有率最高。由於早期檢測測試的可用性和政府針對癌症的配合措施，該領域將在預測期內出現顯著成長。
  • 由於產前疾病患病上升、孕產婦年齡增加、醫療保健支出迅速增加以及先進診斷測試的發展，產前檢測預計將成為同期成長最快的部分。
  • 按地區分類，北美佔市場主導地位，2022 年收益佔有率最大，為 44.87%。由於診斷中心和影像中心基礎的擴大、癌症患者數量的增加、不孕檢測意識的提高以及照護端的快速普及，預計該市場將保持主導地位到2025年檢測設備.馬蘇.

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 ：女性健康診斷市場的變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 女性健康診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章 女性健康診斷：用途估算及趨勢分析

  • 女性健康診斷市場：重點
  • 女性健康診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 癌症
    • 2018年至2030年癌症市場估計與預測
  • 感染疾病
    • 2018年至2030年感染疾病市場估計與預測
  • 骨質疏鬆症
    • 2018年至2030年骨質疏鬆症市場估計與預測
  • 懷孕和生育
    • 2018 年至 2030 年懷孕和生育市場估計和預測
  • 產前
    • 2018年至2030年產前市場估計與預測

第5章 婦女健康診斷：最終用途估計與趨勢分析

  • 女性健康診斷市場：重點
  • 女性健康診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 實驗室
  • 居家照護
  • 其他

第6章 女性健康診斷市場：區域估算與趨勢分析

  • 區域預測
  • 按地區分類的女性健康診斷市場：市場要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • F. Hoffmann-la Roche Ltd.
    • Siemens Aktiengeselischaft
    • Quest Diagnostics incorporated
    • Ge Healthcare
    • Koninklijke Philips NV
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Hologic, Inc.
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.4 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.3% from 2023 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 44.87% in 2022. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Women's Health Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Women's Health Diagnostic Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Women's Health Diagnostic: Application Estimates & Trend Analysis

  • 4.1. Women's Health Diagnostic Market: Key Takeaways
  • 4.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cancer
    • 4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Infectious diseases
    • 4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Osteoporosis
    • 4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pregnancy & fertility
    • 4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Prenatal
    • 4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Women's Health Diagnostic: End-use Estimates & Trend Analysis

  • 5.1. Women's Health Diagnostic Market: Key Takeaways
  • 5.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratory
    • 5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Women's Health Diagnostic Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Women's Health Diagnostic Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-la Roche Ltd.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Aktiengeselischaft
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Quest Diagnostics incorporated
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Ge Healthcare
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Koninklijke Philips N.V.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Abbott Laboratories
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Becton, Dickinson and Company
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hologic, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 17 France women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 31 China women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 32 China women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 36 India women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Thailand women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Women's health diagnostics: market outlook
  • Fig. 9 Women's health diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Women's health diagnostics market driver impact
  • Fig. 15 Women's health diagnostics market restraint impact
  • Fig. 16 Women's health diagnostics market strategic initiatives analysis
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market: Application outlook and key takeaways
  • Fig. 19 Cancer market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 20 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 21 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 22 Pregnancy & fertility market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 23 Prenatal market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 24 Women's health diagnostics market: End-use movement analysis
  • Fig. 25 Women's health diagnostics market: End-use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 27 Laboratory market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 28 Homecare market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 30 Global women's health diagnostics market: Regional movement analysis
  • Fig. 31 Global women's health diagnostics market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Millions)